124 related articles for article (PubMed ID: 18465119)
1. Extremely weak tumor-promoting effect of troglitazone on splenic hemangiosarcomas in rasH2 mice induced by urethane.
Jin M; Matsumoto S; Dewa Y; Nishimura J; Saekusa Y; Hasumi K; Mitsumori K
Arch Toxicol; 2008 Oct; 82(10):771-7. PubMed ID: 18465119
[TBL] [Abstract][Full Text] [Related]
2. Hepatocarcinogenic susceptibility of rasH2 mice to troglitazone in a two-stage hepatocarcinogenesis model.
Jin M; Saekusa Y; Dewa Y; Nishimura J; Matsumoto S; Shibutani M; Hasumi K; Mitsumori K
Arch Toxicol; 2009 Feb; 83(2):173-81. PubMed ID: 18597072
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenic susceptibility of rasH2 mice to troglitazone.
Jin M; Takahashi M; Moto M; Muguruma M; Ito K; Watanabe K; Kenmochi Y; Kono T; Hasumi K; Mitsumori K
Arch Toxicol; 2007 Dec; 81(12):883-94. PubMed ID: 17569031
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous and thiazolidinedione-induced B6C3F1 mouse hemangiosarcomas exhibit low ras oncogene mutation frequencies.
Duddy SK; Gorospe SM; Bleavins MR; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Oct; 160(2):133-40. PubMed ID: 10527912
[TBL] [Abstract][Full Text] [Related]
5. Historical control data of spontaneous tumors in transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice.
Paranjpe MG; Elbekaei RH; Shah SA; Hickman M; Wenk ML; Zahalka EA
Int J Toxicol; 2013; 32(1):48-57. PubMed ID: 23324159
[TBL] [Abstract][Full Text] [Related]
6. p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.
Duddy SK; Parker RF; Bleavins MR; Gough AW; Rowse PE; Gorospe S; Dethloff LA; de la Iglesia FA
Toxicol Appl Pharmacol; 1999 Apr; 156(2):106-12. PubMed ID: 10198275
[TBL] [Abstract][Full Text] [Related]
7. Effect of ethanol on the tumorigenicity of urethane (ethyl carbamate) in B6C3F1 mice.
Beland FA; Benson RW; Mellick PW; Kovatch RM; Roberts DW; Fang JL; Doerge DR
Food Chem Toxicol; 2005 Jan; 43(1):1-19. PubMed ID: 15582191
[TBL] [Abstract][Full Text] [Related]
8. Reduction in the number of animals and the evaluation period for the positive control group in Tg.rasH2 short-term carcinogenicity studies.
Shah SA; Paranjpe MG; Atkins PI; Zahalka EA
Int J Toxicol; 2012; 31(5):423-9. PubMed ID: 22988008
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of cyclin D1 in pulmonary proliferative lesions induced by high doses of urethane in transgenic mice carrying the human prototype c-H-ras gene.
Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Yanai T; Masegi T; Mitsumori K
J Vet Med Sci; 2001 Mar; 63(3):261-8. PubMed ID: 11307925
[TBL] [Abstract][Full Text] [Related]
10. Gene expression analysis in the lung of the rasH2 transgenic mouse at week 4 prior to induction of malignant tumor formation by urethane and N-methylolacrylamide.
Tsuji S; Kuwahara Y; Takagi H; Sugiura M; Nakanishi Y; Wakamatsu M; Tsuritani K; Sato Y
J Toxicol Sci; 2015 Dec; 40(6):685-700. PubMed ID: 26558449
[TBL] [Abstract][Full Text] [Related]
11. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
Mitsumori K; Koizumi H; Nomura T; Yamamoto S
Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
[TBL] [Abstract][Full Text] [Related]
12. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.
Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T
Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579
[TBL] [Abstract][Full Text] [Related]
13. Lack of modifying effects of eugenol on development of lung proliferative lesions induced by urethane in transgenic mice carrying the human prototype c-Ha-ras gene.
Koujitani T; Yasuhara K; Tamura T; Onodera H; Takagi H; Takizawa T; Hirose M; Hayashi Y; Mitsumori K
J Toxicol Sci; 2001 Aug; 26(3):129-39. PubMed ID: 11552296
[TBL] [Abstract][Full Text] [Related]
14. Relationship of body weight parameters with the incidence of common spontaneous tumors in Tg.rasH2 mice.
Paranjpe MG; Denton MD; Vidmar TJ; Elbekai RH
Toxicol Pathol; 2014 Oct; 42(7):1143-52. PubMed ID: 24292389
[TBL] [Abstract][Full Text] [Related]
15. Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice.
Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H
J Toxicol Sci; 2001 May; 26(2):61-73. PubMed ID: 11429969
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and carcinogensis. Studies of urethane, ethanol, and urethane/ethanol (urethane, CAS No. 51-79-6; ethanol, CAS No. 64-17-5) in B6C3F1 mice (drinking water studies).
Natl Toxicol Program Tech Rep Ser; 2004 Aug; (510):1-346. PubMed ID: 15625555
[TBL] [Abstract][Full Text] [Related]
17. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study.
Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K
Cancer Lett; 2000 May; 152(2):211-6. PubMed ID: 10773414
[TBL] [Abstract][Full Text] [Related]
18. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice.
Okamura M; Moto M; Kashida Y; Machida N; Mitsumori K
Toxicol Pathol; 2004; 32(4):474-81. PubMed ID: 15223773
[TBL] [Abstract][Full Text] [Related]
20. Hepatocarcinogenic susceptibility of fenofibrate and its possible mechanism of carcinogenicity in a two-stage hepatocarcinogenesis model of rasH2 mice.
Kawai M; Jin M; Nishimura J; Dewa Y; Saegusa Y; Matsumoto S; Taniai E; Shibutani M; Mitsumori K
Toxicol Pathol; 2008 Dec; 36(7):950-7. PubMed ID: 18978307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
